Welltower Inc. $WELL Shares Sold by VestGen Advisors LLC

VestGen Advisors LLC reduced its stake in Welltower Inc. (NYSE:WELL) by 60.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,187 shares of the real estate investment trust’s stock after selling 4,957 shares during the period. VestGen Advisors LLC’s holdings in Welltower were worth $734,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the stock. Bank of America Corp DE purchased a new position in Welltower during the second quarter valued at approximately $4,425,089,000. Legal & General Group Plc purchased a new stake in Welltower during the second quarter worth $1,599,351,000. BlackRock Inc. lifted its holdings in Welltower by 5.5% during the second quarter. BlackRock Inc. now owns 78,049,214 shares of the real estate investment trust’s stock worth $17,714,830,000 after buying an additional 4,045,458 shares during the period. Canada Pension Plan Investment Board bought a new stake in Welltower during the 2nd quarter valued at $528,400,000. Finally, Amundi boosted its position in Welltower by 60.3% during the 2nd quarter. Amundi now owns 5,339,664 shares of the real estate investment trust’s stock valued at $1,211,944,000 after acquiring an additional 2,008,543 shares in the last quarter. 94.80% of the stock is owned by hedge funds and other institutional investors.

Key Welltower News

Here are the key news stories impacting Welltower this week:

• Positive Sentiment: Welltower lifted its outlook after reporting strong growth in senior housing, providing the clearest near-term catalyst for the stock. The update suggests improving occupancy, pricing, or operating trends could support future earnings and cash flow. Welltower stock lifts outlook after strong senior housing growth
• Positive Sentiment: Freedom Broker upgraded Welltower’s depositary receipt from “hold” to “buy,” adding to the positive analyst sentiment surrounding the company. Freedom Broker upgrades Welltower
• Positive Sentiment: Coverage following the third-quarter update highlighted the raised outlook and senior-housing momentum, helping support the view that Welltower can continue benefiting from favorable demographic trends. Welltower stock after Q3 outlook lift
• Neutral Sentiment: Potential Social Security reform could materially affect seniors’ disposable income and therefore demand for senior housing, but the timing and details remain uncertain. Social Security reform and Welltower demand
• Neutral Sentiment: Raymond James lowered its price target to $263 but maintained a favorable view, calling Welltower a strong large-cap option. Cantor Fitzgerald also trimmed its target to $258 while retaining an “overweight” rating. These reductions may reflect valuation discipline rather than a change in the long-term outlook. Raymond James lowers Welltower price target
• Negative Sentiment: One market report characterized the shares as falling after an earnings miss, which could weigh on sentiment; however, the broader earnings coverage and company outlook update point to stronger-than-expected operating momentum. Welltower shares after earnings

Insider Buying and Selling

In other Welltower news, Director Andrew Gundlach bought 5,000 shares of Welltower stock in a transaction dated Wednesday, August 26th. The stock was acquired at an average cost of $242.06 per share, for a total transaction of $1,210,300.00. Following the completion of the transaction, the director directly owned 30,000 shares of the company’s stock, valued at approximately $7,261,800. This represents a 20.00% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Purchased indirectly through two trusts. The transaction was executed in multiple trades at prices ranging from $241.59 to $242.59. The reported $242.06 price is the weighted-average purchase price. Corporate insiders own 0.37% of the company’s stock.

Welltower Stock Up 0.5%

WELL stock opened at $234.43 on Friday. The firm’s fifty day simple moving average is $233.51 and its 200-day simple moving average is $218.24. The company has a market capitalization of $171.98 billion, a P/E ratio of 101.48, a price-to-earnings-growth ratio of 1.13 and a beta of 0.75. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.16 and a quick ratio of 3.16. Welltower Inc. has a 12 month low of $178.19 and a 12 month high of $255.20.

Welltower (NYSE:WELL) last announced its quarterly earnings results on Monday, October 26th. The real estate investment trust reported $1.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.03. Welltower had a net margin of 12.08% and a return on equity of 3.61%. The firm had revenue of $3.72 billion for the quarter, compared to the consensus estimate of $3.64 billion. During the same period in the prior year, the firm posted $1.34 earnings per share. The firm’s quarterly revenue was up 38.4% compared to the same quarter last year. As a group, equities research analysts forecast that Welltower Inc. will post 6.49 earnings per share for the current year.

Welltower Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 19th. Investors of record on Tuesday, November 10th will be given a dividend of $0.85 per share. This represents a $3.40 annualized dividend and a dividend yield of 1.5%. The ex-dividend date is Tuesday, November 10th. Welltower’s payout ratio is presently 147.19%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on WELL. Barclays cut their price target on Welltower from $259.00 to $246.00 and set an “equal weight” rating on the stock in a report on Tuesday, October 13th. Citigroup upped their price objective on Welltower from $255.00 to $275.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Cantor Fitzgerald cut their target price on Welltower from $260.00 to $258.00 and set an “overweight” rating on the stock in a research note on Thursday. Freedom Broker upgraded shares of Welltower from a “hold” rating to a “buy” rating and set a $255.00 target price for the company in a report on Wednesday. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $263.00 target price on shares of Welltower in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $259.81.

About Welltower

Welltower Inc (NYSE: WELL) is a healthcare-focused real estate investment trust that owns, develops, and manages properties used to provide healthcare and related services. Its portfolio is centered on senior housing communities, outpatient medical facilities, and post-acute care properties, including assets operated by healthcare providers and senior living companies.

The company’s senior housing investments support independent living, assisted living, and memory care services. Its outpatient medical properties accommodate physicians, clinics, and other healthcare providers, while its broader healthcare real estate portfolio is designed to serve demand for care delivered outside traditional hospitals.